The COVID-19 Antigen Rapid Test is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab or nasal swab from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
Catalog No. | Specifications | Reaction Time | Sensitivity | Specificity | Storage Condition | Shelf Life | Certification |
---|---|---|---|---|---|---|---|
ICOVv002-B025 | 25 tests/box | 15 mins | For nasopharyngeal swab: 96.7% (95%CI: 91.7%~98.7%) For nasal swab: 91.4% (95%CI: 85.9%~94.9%) | For nasopharyngeal swab: 100% (95%CI: 99.2%~100%) For nasal swab: 99.4% (95%CI: 98.1%~99.8%) | 4-30℃ | 24 months | TGA |
This product cannot be sold in the United States.